Levacide Pour-on Solution 20% w/v

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: VMD (Veterinary Medicines Directorate)

Ingredjent attiv:

Levamisole Hydrochloride

Disponibbli minn:

Norbrook Laboratories Limited

Kodiċi ATC:

QP52AE01

INN (Isem Internazzjonali):

Levamisole Hydrochloride

Għamla farmaċewtika:

Pour-on solution

Tip ta 'preskrizzjoni:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupp terapewtiku:

Cattle

Żona terapewtika:

Anthelmintic

L-istatus ta 'awtorizzazzjoni:

Authorized

Data ta 'l-awtorizzazzjoni:

1997-10-07

Karatteristiċi tal-prodott

Revised: 17
th
December 2008
AN: 00809/2008
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Levacide Pour-On Solution 20 %w/v
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE: W/V
Levamisole
20.0 %
(as Levamisole Hydrochloride
26.2 %)
EXCIPIENTS:
Patent blue (E131)
0.1 %
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Pour-on solution.
A dark blue solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Levamisole is a broad-spectrum anthelmintic indicated for use in
cattle in the
treatment and control of nematode infections such as parasitic
gastro-enteritis
and
lungworm
disease
caused
by
the
following
mature
and
developing
immature gastro-intestinal and pulmonary nematodes:
Lungworms - _Dictyocaulus viviparus_
Gastrointestinal
worms
-
_Trichostrongylus_
spp,
_Cooperia_
spp,
_Ostertagia_
_ostertagi_
(except
inhibited
_O. _
_ostertagi_
larvae),
_Haemonchus_
spp,
_Nematodirus_ spp, _Bunostomum_ spp, _Oesophagostomum_ spp.
Revised: 17
th
December 2008
AN: 00809/2008
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In cases of lungworm infection coughing may persist for some time
after
treatment due to tissue damage.
For external use only.
Do not treat animals when wet, and where possible, for one hour post
treatment, prevent treated animals from being exposed to rain.
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Care should be taken to avoid the following practices because they
increase
the risk of development of resistance and could ultimately result in
ineffective
therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over
an extended period of time.
•
Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device (if any).
Suspected
clinical
cases
of
resistance
to
anthelmintics
should
be
further
investigated using appropriate tests (e